Argent Advisors, Inc. Bristol Myers Squibb CO Transaction History

Argent Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$68.48 - $81.09 $13,696 - $16,218	-200 Reduced 6.39%	2,930 $210,000
Q2 2022 Aug 08, 2022	BUY	$72.62 - $79.98 $3,631 - $3,999	50 Added 1.62%	3,130 $241,000
Q1 2022 Apr 26, 2022	SELL	$61.48 - $73.72 $78,694 - $94,361	-1,280 Reduced 29.36%	3,080 $225,000
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $2,681 - $3,126	50 Added 1.16%	4,360 $272,000
Q3 2021 Nov 05, 2021	SELL	$59.17 - $69.31 $13,372 - $15,664	-226 Reduced 4.98%	4,310 $255,000
Q2 2021 Aug 02, 2021	BUY	$61.91 - $67.42 $41,046 - $44,699	663 Added 17.12%	4,536 $303,000
Q1 2021 Apr 27, 2021	SELL	$59.34 - $66.74 $5,934 - $6,673	-100 Reduced 2.52%	3,873 $245,000
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $416,709 - $472,208	-7,217 Reduced 64.5%	3,973 $246,000
Q3 2020 Oct 29, 2020	BUY	$57.43 - $63.64 $18,377 - $20,364	320 Added 2.94%	11,190 $675,000
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $76,090 - $88,956	1,388 Added 14.64%	10,870 $639,000
Q1 2020 Apr 23, 2020	BUY	$46.4 - $67.43 $122,032 - $177,340	2,630 Added 38.38%	9,482 $529,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $337,186 - $439,829	6,852 New	6,852 $449,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Argent Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Argent Advisors, Inc. with notifications on news.